Vanberra Signal

Accutar Biotechnology

Curated by Signal

Provider of AI assisted drug discovery tool

Overview

Accutar Biotechnology is engaged in the development of ts in computation-aided drug discovery. They have developed an AI-assisted tool for Drug pocket side-chain conformation prediction and drug docking with significantly increased accuracy compared to the standard method of Prediction of chemical compound characteristics such as solubility, binding affinity, etc. Their platforms are termed Orbital Docking platforms and One-click docking.

Key facts

Founded
2015

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Provider of hardware and software solution for cannabis retailers

    Health TechnologyCharlotte, United States
  • AI powered health navigator providing personalized joint and muscle pain guidance

    Health TechnologySan Francisco, United States
  • Digital skin image analysis and disease detection tool for providers

    Health TechnologyNew Haven, United States

About Accutar Biotechnology

What does Accutar Biotechnology do?

Accutar Biotechnology is engaged in the development of ts in computation-aided drug discovery.

Where is Accutar Biotechnology headquartered?

Accutar Biotechnology is headquartered in Brooklyn, United States.

When was Accutar Biotechnology founded?

Accutar Biotechnology was founded in 2015.

Which sector is Accutar Biotechnology in?

Accutar Biotechnology operates in Health Technology.

Who are Accutar Biotechnology's competitors?

Companies similar to Accutar Biotechnology include C-Trax, Nora Health AI, and 3Derm.